These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Excretion of triamterene and its metabolite in triamterene stone patients. Ettinger B J Clin Pharmacol; 1985; 25(5):365-8. PubMed ID: 4031113 [TBL] [Abstract][Full Text] [Related]
28. Drug-induced renal stones: incidence, clinical expression and stone analysis. Rapado A; Traba ML; Caycho C; Cifuentes-Delatte L Contrib Nephrol; 1987; 58():25-9. PubMed ID: 2826078 [No Abstract] [Full Text] [Related]
31. [Acute kidney failure caused by triamterene and hydrochlorothiazide]. Heitmann D; Rumpf KW; Scheler F Dtsch Med Wochenschr; 1982 May; 107(21):836. PubMed ID: 7075507 [No Abstract] [Full Text] [Related]
32. Role of zinc in nephrolithiasis. Gupta A; Srivastava DK; Kumar S J Indian Med Assoc; 1984 Jul; 82(7):235-7. PubMed ID: 6545899 [No Abstract] [Full Text] [Related]
33. [Nephrolithiasis in a HIV infected patient treated with indinavir]. Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Myśliwiec M Przegl Lek; 2001; 58(6):528-9. PubMed ID: 11816748 [TBL] [Abstract][Full Text] [Related]
35. [Nephrolithiasis induced by hyperparathyroidism]. Marković V; Macura D Srp Arh Celok Lek; 1974 Feb; 102(2):101-10. PubMed ID: 4410206 [No Abstract] [Full Text] [Related]
36. [Significance of mucopolysaccharide structural changes in the pathogenesis and diagnosis of nephrolithiasis]. Borisova-Khromenko VM; Berezin IuV; Maletin AG; Neĭmark AI Urol Nefrol (Mosk); 1981; (1):18-20. PubMed ID: 6451975 [No Abstract] [Full Text] [Related]
37. [Lipid peroxidation in patients with nephrolithiasis and chronic pyelonephritis in the remission stage]. Golovanov SA; Drozhzheva VV Urol Nefrol (Mosk); 1995; (2):21-2. PubMed ID: 7785114 [TBL] [Abstract][Full Text] [Related]
38. Non-obstructive nephrolithiasis: metabolic and immunopathological studies. Jeantet A; Tetta C; Camussi G; Ferrando U; Rotunno M; Thea A; Gaido M; Vercellone A Contrib Nephrol; 1985; 49():123-7. PubMed ID: 3913569 [No Abstract] [Full Text] [Related]
39. Exacerbation of nephrolithiasis by a carbonic anhydrase inhibitor. Wallace MR; MacDiarmid J; Reeder J N Z Med J; 1974 Feb; 79(509):687-90. PubMed ID: 4522951 [No Abstract] [Full Text] [Related]
40. [Determination of calcium, oxalate and inhibitory activity of the urine in patients with calcium nephrolithiasis]. Han KH; Cao LC; Ying YL Zhonghua Wai Ke Za Zhi; 1986 Mar; 24(3):173-5, 190. PubMed ID: 3757655 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]